Learn more about OncoSynergy
targeting rare and resistant cancers
Other Solid Cancers
Ovarian and pancreatic cancer, and malignant meningioma.
Glioblastoma
Our primary focus. The most common and malignant primary brain cancer.
Hematological Maligancies
Drug resistant acute lymphoblastic leukemia.
THERAPEUTIC PLATFORMS
First-in-class humanized and deimmunized pan-CD29 monoclonal antibody
Best-in-class small molecule heat shock protein modulator
Partners and Collaborators
